Drug application
LUSEDRA (FOSPROPOFOL DISODIUM)
Drugs@FDA NDA 022244 · EISAI INC
Key facts
| Drug name | LUSEDRA |
|---|---|
| Active ingredients | FOSPROPOFOL DISODIUM |
| Application type | NDA |
| Application number | 022244 |
| Company | EISAI INC |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 1050MG/30ML (35MG/ML) |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Dec 8, 2008 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.